Optimal design for multi-arm multi-stage clinical trials

被引：0
|
作者：
James MS Wason
Thomas Jaki
机构：
[1] MRC Biostatistics Unit,Medical and Pharmaceutical Statistics Research Unit
[2] Lancaster University,undefined
来源：
Trials | / 12卷 / Suppl 1期
关键词：
Optimal Design; Active Treatment; Drug Development; Specific Design; Sufficient Evidence;
D O I：
10.1186/1745-6215-12-S1-A4
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] How do multi-stage, multi-arm trials compare to the traditional two-arm parallel group design - a reanalysis of 4 trials
    Barthel, F. M-S
    Parmar, M. K. B.
    Royston, P.
    [J]. TRIALS, 2009, 10
  • [42] How do multi-stage, multi-arm trials compare to the traditional two-arm parallel group design – a reanalysis of 4 trials
    FM-S Barthel
    MKB Parmar
    P Royston
    [J]. Trials, 10
  • [43] Designing a multi-arm multi-stage trial for Parkinson's
    Zeissler, M. L.
    Allison, J.
    Athauda, D.
    Pires, S. Bartolomeu
    Baxendale, G.
    Bhatia, K.
    Breen, D.
    Chapman, R.
    Collins, H.
    Croucher, R.
    Ellis-Doyle, R.
    Gonzales-Robles, C.
    Hudson, F.
    Khengar, R.
    Korlipara, P.
    Lambert, C.
    Mills, G.
    Morgan, A.
    Morris, H.
    Rudiger, J.
    Silverdale, M.
    Wonnacott, S.
    Yarnall, A.
    Foltynie, T.
    Carroll, C.
    Mullin, S.
    [J]. MOVEMENT DISORDERS, 2022, 37 : S362 - S362
  • [44] Multi-arm, multi-stage randomised controlled trials for evaluating therapeutic HIV cure interventions
    Moore, Cecilia L.
    Stohr, Wolfgang
    Crook, Angela M.
    Richert, Laura
    Lelievre, Jean-Daniel
    Pantaleo, Giuseppe
    Garcia, Felipe
    Vella, Stefano
    Levy, Yves
    Thiebaut, Rodolphe
    McCormack, Sheena
    [J]. LANCET HIV, 2019, 6 (05): : E334 - E340
  • [45] A generalized Dunnett test for multi-arm multi-stage clinical studies with treatment selection
    Magirr, D.
    Jaki, T.
    Whitehead, J.
    [J]. BIOMETRIKA, 2012, 99 (02) : 494 - 501
  • [46] Group sequential multi-arm multi-stage survival trial design with treatment selection
    Wu, Jianrong
    Li, Yimei
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2024, 34 (04) : 453 - 468
  • [47] Simulation optimization for Bayesian multi-arm multi-stage clinical trial with binary endpoints
    Yu, Zhenning
    Ramakrishnan, Viswanathan
    Meinzer, Caitlyn
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2019, 29 (02) : 306 - 317
  • [48] Type I error rates of multi-arm multi-stage clinical trials: strong control and impact of intermediate outcomes
    Daniel J. Bratton
    Mahesh K. B. Parmar
    Patrick P. J. Phillips
    Babak Choodari-Oskooei
    [J]. Trials, 17
  • [49] Type I error rates of multi-arm multi-stage clinical trials: strong control and impact of intermediate outcomes
    Bratton, Daniel J.
    Parmar, Mahesh K. B.
    Phillips, Patrick P. J.
    Choodari-Oskooei, Babak
    [J]. TRIALS, 2016, 17
  • [50] Developing infrastructure for a multi-arm multi-stage trial in Parkinson's
    Zeissler, M. L.
    Allison, J.
    Athauda, D.
    Pires, S. Bartolomeu
    Baxendale, G.
    Bhatia, K.
    Breen, D.
    Chapman, R.
    Collins, H.
    Croucher, R.
    Ellis-Doyle, R.
    Gonzales-Robles, C.
    Hudson, F.
    Khengar, R.
    Korlipara, P.
    Lambert, C.
    Mills, G.
    Morgan, A.
    Morris, H.
    Rudiger, J.
    Silverdale, M.
    Wonnacott, S.
    Yarnall, A.
    Foltynie, T.
    Carroll, C.
    Mullin, S.
    [J]. MOVEMENT DISORDERS, 2022, 37 : S362 - S362
12345